Abstract
We externally validated a clinically useful tool that predicts benign prostate pathology on magnetic resonance imaging/ultrasound fusion–targeted biopsy in men with a prior negative 12-core systematic biopsy and updated this predictive tool to improve its performance in patient counseling regarding the need for a repeat biopsy.
Original language | English (US) |
---|---|
Pages (from-to) | 815-822 |
Number of pages | 8 |
Journal | European Urology Focus |
Volume | 5 |
Issue number | 5 |
DOIs | |
State | Published - Sep 2019 |
Keywords
- Benign
- External validation
- Magnetic resonance imaging/ultrasound fusion–targeted prostate biopsy
- Nomogram
- Prior negative biopsy
- Prostate cancer
ASJC Scopus subject areas
- Urology